DFX Intelligence

Data Factory

Alcanza Clinical Research

Private Credit

Search this name across graphsid dfx:pc:3dca8408-37ad-d27a-14bc-6ef5f5e7fef7

Data as of Jun 30, 2026 (this record's last observation) from The BDC tape; Adviser-reported credit funds; Deal parties; Pending. Page built Sep 20, 2026, 3:53 AM UTC and rebuilt at most every 15 minutes.

Relationships: 0
Dated events: 17
On other graphs: 1
Observed: Mar 31, 2023 to Jun 30, 2026
1 observations

Across DFX

same identity by shared identifier, citation, or a bridge measured by hand

Private Equityidentity

Alcanza Clinical Research

name equal multitoken · confidence 50% · family precision 100%

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Lenders: 1
BDCs: 1
Facilities: 4
First on a schedule: Mar 31, 2023
Last on a schedule: Jun 30, 2026

Facilities

one facility is one borrower, one kind and one lien; its size is the sum of the BDC pieces the tape can see, a lower bound, never the commitment

Kind	Lien	Size, lower bound	Fair value	Maturity	Maturity basis	Spread	PIK	Lenders	BDCs	Status	Last seen
Delayed draw	unknown	n/a	n/a	n/a	n/a	n/a	n/a	1	1	Unknown	Jun 30, 2026
Term loan	First lien	$7.1M	$7.1M	Dec 31, 2027	Xbrl fact	0	n/a	1	1	Unknown	Mar 31, 2026
revolver	First lien	n/a	n/a	Dec 31, 2027	Xbrl fact	n/a	n/a	1	1	Unknown	Mar 31, 2026
Delayed draw	First lien	n/a	$-6,000	Dec 1, 2027	Ident text	n/a	n/a	1	1	Unknown	Jun 30, 2023

Lenders holding it now

each BDC's own pieces on its latest schedule, folded to one row per lender; every amount is that BDC's piece as filed, so a sum is a lower bound

BDC	Pieces	Principal	Fair value	Unfunded	Nearest maturity	As of
Crescent Capital BDC, Inc.	1	$0	$0	$0	n/a	Jun 30, 2026

Relationships

No published relationship touches this entity yet.

Dated events

9 bookkeeping events (roster, classification and holdings changes) folded below

Occurred
Mar 31, 2026
Borrower left every BDC schedule
Alcanza Clinical Research term loan (first lien) left every BDC schedule after 2026-03-31 (1 lender, $7.1M last held)
BDC schedule of investments
$7.1M
Occurred
Mar 31, 2026
Borrower left every BDC schedule
Alcanza Clinical Research revolver (first lien) left every BDC schedule after 2026-03-31 (1 lender, $.0M last held)
BDC schedule of investments
Occurred
Sep 30, 2023
Coupon changed
Alcanza Clinical Research term loan: spread moved from 5.25% to 6.00%
BDC schedule of investments
$7.3M
Occurred
Sep 30, 2023
Spread increased
Crescent Capital BDC, Inc.: spread increased in Alcanza Clinical Research (5.25% to 6.00%)
BDC schedule of investmentsobserved 2.9 years ago
0.06 usd
Occurred
Jun 30, 2023
Borrower left every BDC schedule
Alcanza Clinical Research delayed draw (first lien) left every BDC schedule after 2023-06-30 (1 lender, $.0M last held)
BDC schedule of investments
Occurred
Jun 30, 2023
Mark recovered
Crescent Capital BDC, Inc.: fair value recovery in Alcanza Clinical Research (-200 to -150 cents on cost)
BDC schedule of investmentsobserved 3.1 years ago
-1.5 usd
Occurred
Jun 30, 2023
Mark recovered
Crescent Capital BDC, Inc.: fair value recovery in Alcanza Clinical Research (-175 to -150 cents on cost)
BDC schedule of investmentsobserved 3.1 years ago
-1.5 usd
Occurred
Mar 31, 2023
Borrower first appears on a BDC schedule
Alcanza Clinical Research first appears in a BDC schedule (1 lender)
Crescent Capital BDC, Inc.BDC schedule of investmentsobserved 3.4 years ago
$7.1M

Show 9 bookkeeping events

Occurred
Jun 30, 2026
Crescent Capital BDC, Inc.: new position in Alcanza Clinical Research
Occurred
Jun 30, 2026
Crescent Capital BDC, Inc.: position exited in Alcanza Clinical Research
Occurred
Jun 30, 2026
Crescent Capital BDC, Inc.: position exited in Alcanza Clinical Research ($7.1M principal)
Occurred
Mar 31, 2026
Crescent Capital BDC, Inc.: position exited in Alcanza Clinical Research
Occurred
Dec 31, 2025
Crescent Capital BDC, Inc.: new position in Alcanza Clinical Research
Occurred
Sep 30, 2023
Crescent Capital BDC, Inc.: position exited in Alcanza Clinical Research
Occurred
Mar 31, 2023
Crescent Capital BDC, Inc.: new position in Alcanza Clinical Research
Occurred
Mar 31, 2023
Crescent Capital BDC, Inc.: new position in Alcanza Clinical Research
Occurred
Mar 31, 2023
Crescent Capital BDC, Inc.: new position in Alcanza Clinical Research ($7.1M principal)

Provenance

Graph: Private Credit
Canonical id: dfx:pc:3dca8408-37ad-d27a-14bc-6ef5f5e7fef7
First observed: Mar 31, 2023
Last observed: Jun 30, 2026 2 months ago
Resolution: Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.

Alcanza Clinical Research

Private Credit

Search this name across graphsid dfx:pc:3dca8408-37ad-d27a-14bc-6ef5f5e7fef7

Kind

Lien

Size, lower bound

Fair value

Maturity

Maturity basis

Spread

PIK

Lenders

BDCs

Status

Last seen

Delayed draw

unknown

n/a

Unknown

Jun 30, 2026

Term loan

First lien

$7.1M

Dec 31, 2027

Xbrl fact

n/a

Unknown

Mar 31, 2026

revolver

First lien

n/a

Dec 31, 2027

Xbrl fact

n/a

Unknown

Mar 31, 2026

Delayed draw

First lien

n/a

$-6,000

Dec 1, 2027

Ident text

n/a

Unknown

Jun 30, 2023

BDC

Pieces

Principal

Fair value

Unfunded

Nearest maturity

As of

Crescent Capital BDC, Inc.

n/a

Jun 30, 2026